Health Technology · Pharmaceuticals: Major · NSE: THEMISMED · data 2026-10-09

Themis Medicare Limited

Health check: Average (5/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹108.57

Market cap

₹1,006 cr

P/E

25.1

P/B

—

ROE

0.3%

ROCE

-2.3%

Debt / equity

0.25

Dividend yield

0.46%

1-year return

-12.6%

52-week high

₹140.6

52-week low

₹64.95

Operating margin

-15.8%

Growth

Revenue (last 12 months)	₹332 cr
Net profit (last 12 months)	₹40 cr
Sales growth, 3 years (yearly)	-1.2%
Profit growth, 3 years (yearly)	-72.8%

Similar companies

Lincoln Pharmaceuticals Ltd (LINCOLN) · Sigachi Industries Limited (SIGACHI) · Bajaj Healthcare Ltd (BAJAJHCARE) · Bafna Pharmaceuticals Limited (BAFNAPH) · Shree Ganesh Remedies Ltd. (SGRL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open THEMISMED in NSE Scanner →